SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Peter Conner, Sven Gustafsson, Marius Kublickas, First trimester contingent testing with either nuchal translucency or cell-free DNA. Cost efficiency and the role of ultrasound dating, Acta Obstetricia et Gynecologica Scandinavica, 2015, 94, 4
  2. 2
    Howard Cuckle, Prenatal Screening Using Maternal Markers, Journal of Clinical Medicine, 2014, 3, 2, 504

    CrossRef

  3. 3
    José A. Sainz, Rosa Serrano, Carlota Borrero, Enriqueta Turmo, First trimester contingent test as a screening method for Down’s syndrome. A prospective study in the general population, Journal of Maternal-Fetal and Neonatal Medicine, 2012, 25, 11, 2221

    CrossRef

  4. 4
    Paolo Guanciali-Franchi, Irene Iezzi, Alessandra Soranno, Chiara Palka-Bayard Volo, Melissa Alfonsi, Giuseppe Calabrese, Peter Benn, Optimal cut-offs for down syndrome contingent screening in a population of 10 156 pregnant women, Prenatal Diagnosis, 2012, 32, 12
  5. 5
    M. P. H. Koster, E. J. Wortelboer, P. Stoutenbeek, G. H. A. Visser, P. C. J. I. Schielen, Modeling Down syndrome screening performance using first-trimester serum markers, Ultrasound in Obstetrics & Gynecology, 2011, 38, 2
  6. You have free access to this content6
    Kypros H. Nicolaides, Screening for fetal aneuploidies at 11 to 13 weeks, Prenatal Diagnosis, 2011, 31, 1
  7. 7
    D. S. Sahota, T. Y. Leung, L. W. Chan, L. W. Law, T. Y. Fung, M. Chen, T. K. Lau, Comparison of first-trimester contingent screening strategies for Down syndrome, Ultrasound in Obstetrics & Gynecology, 2010, 35, 3
  8. 8
    Kai Muru, Mari Sitska, Karin Asser, Aivar Ehrenberg, Helle Karro, Katrin Õunap, Tiia Reimand, Prospective experience with contingent screening strategy for Down syndrome in Estonia, Journal of Community Genetics, 2010, 1, 3, 133

    CrossRef

  9. You have free access to this content9
    K. O. Kagan, I. Staboulidou, J. Cruz, D. Wright, K. H. Nicolaides, Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing, Ultrasound in Obstetrics & Gynecology, 2010, 36, 5
  10. 10
    Thenmalar Vadiveloo, Jennifer A. Crossley, David A. Aitken, First-trimester contingent screening for Down syndrome can reduce the number of nuchal translucency measurements required, Prenatal Diagnosis, 2009, 29, 1
  11. 11
    Michael Christiansen, Placental growth hormone and growth hormone binding protein are first trimester maternal serum markers of Down syndrome, Prenatal Diagnosis, 2009, 29, 13
  12. 12
    Valerie Seror, Yves Ville, Prenatal screening for Down syndrome: women's involvement in decision-making and their attitudes to screening, Prenatal Diagnosis, 2009, 29, 2
  13. 13
    Kasper Pihl, Torben Larsen, Steen Rasmussen, Lone Krebs, Michael Christiansen, The proform of eosinophil major basic protein: a new maternal serum marker for adverse pregnancy outcome, Prenatal Diagnosis, 2009, 29, 11
  14. You have free access to this content14
    Howard S. Cuckle, Fergal D. Malone, David Wright, T. Flint Porter, David A. Nyberg, Christine H. Comstock, George R. Saade, Richard L. Berkowitz, Jose C. Ferreira, Lorraine Dugoff, Sabrina D. Craigo, Ilan E. Timor, Stephen R. Carr, Honor M. Wolfe, Mary E. D'Alton, Contingent screening for Down syndrome—results from the FaSTER trial, Prenatal Diagnosis, 2008, 28, 2
  15. 15
    Kasper Pihl, Torben Larsen, Lone Krebs, Michael Christiansen, First trimester maternal serum PAPP-A, β-hCG and ADAM12 in prediction of small-for-gestational-age fetuses, Prenatal Diagnosis, 2008, 28, 12
  16. 16
    Michael Christiansen, Kevin Spencer, Jennie Laigaard, Nicholas J. Cowans, Severin Olesen Larsen, Ulla M. Wewer, ADAM 12 as a second-trimester maternal serum marker in screening for Down syndrome, Prenatal Diagnosis, 2007, 27, 7
  17. You have free access to this content17
    Kevin Spencer, Aneuploidy screening in the first trimester, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2007, 145C, 1
  18. 18
    Michael Christiansen, Tina Lindvig Sørensen, Bent Nørgaard-Pedersen, Human placental lactogen is a first-trimester maternal serum marker of Down syndrome, Prenatal Diagnosis, 2007, 27, 1
  19. 19
    K. H. Nicolaides, R. Bindra, O. M. Turan, I. Chefetz, M. Sammar, H. Meiri, J. Tal, H. S. Cuckle, A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound, Ultrasound in Obstetrics & Gynecology, 2006, 27, 1
  20. 20
    Jennie Laigaard, Kevin Spencer, Michael Christiansen, Nicholas J. Cowans, Severin Olesen Larsen, Bent Norgaard Pedersen, Ulla M. Wewer, ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome, Prenatal Diagnosis, 2006, 26, 10
  21. 21
    Jennie Laigaard, Howard Cuckle, Ulla M. Wewer, Michael Christiansen, Maternal serum ADAM12 levels in Down and Edwards' syndrome pregnancies at 9–12 weeks' gestation, Prenatal Diagnosis, 2006, 26, 8
  22. 22
    W. J. A. Gyselaers, E. R. A. Roets, C. D. Y. J. Van Holsbeke, A. J. Vereecken, E. J. H. Van Herck, D. P. L. Straetmans, W. U. A. M. Ombelet, J. G. Nijhuis, Sequential triage in the first trimester may enhance advanced ultrasound scanning in population screening for trisomy 21, Ultrasound in Obstetrics & Gynecology, 2006, 27, 6
  23. 23
    Dave Wright, Ian Bradbury, Howard Cuckle, Jason Gardosi, Ann Tonks, Sue Standing, Peter Benn, Three-stage contingent screening for Down syndrome, Prenatal Diagnosis, 2006, 26, 6
  24. 24
    W. Gyselaers, A. Vereecken, J. Nijhuis, Fetal aneuploidy screening practice in Flanders and Belgium, International Congress Series, 2005, 1279, 228

    CrossRef

  25. 25
    Wilfried J. A. Gyselaers, Annie J. Vereecken, Erik J. H. Van Herck, Dany P. L. Straetmans, Eric T. M. de Jonge, Willem U. A. M. Ombelet, Jan G. Nijhuis, Population screening for fetal trisomy 21: easy access to screening should be balanced against a uniform ultrasound protocol, Prenatal Diagnosis, 2005, 25, 11
  26. 26
    Peter Benn, Dave Wright, Howard Cuckle, Practical strategies in contingent sequential screening for Down syndrome, Prenatal Diagnosis, 2005, 25, 8
  27. 27
    Ron Maymon, Howard Cuckle, Rick Jones, Orit Reish, Reuven Sharony, Arie Herman, Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening, Prenatal Diagnosis, 2005, 25, 12
  28. 28
    Tina Sørensen, Severin Olesen Larsen, Michael Christiansen, Weight adjustment of serum markers in early first-trimester prenatal screening for Down syndrome, Prenatal Diagnosis, 2005, 25, 6
  29. 29
    Severin Olesen Larsen, Michael Christiansen, Bent Norgaard-Pedersen, Which contingent sequential screening protocol?, Prenatal Diagnosis, 2005, 25, 12
  30. 30
    Dave Wright, Ian Bradbury, Peter Benn, Howard Cuckle, Karen Ritchie, Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening, Prenatal Diagnosis, 2004, 24, 10
  31. 31
    Brian Kott, Theodore J Dubinsky, Cost-effectiveness model for first-trimester versus second-trimester ultrasound screening for down syndrome, Journal of the American College of Radiology, 2004, 1, 6, 415

    CrossRef

  32. 32
    M Christiansen, SO Larsen, C Oxvig, Q-P Qin, JM Wagner, MT Overgaard, GJ Gleich, L Sottrup-Jensen, B Nørgaard-Pedersen, Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers, Clinical Genetics, 2004, 65, 1
  33. You have free access to this content33
    Current Awareness in prenatal diagnosis, Prenatal Diagnosis, 2002, 22, 9
  34. 34
    Howard S. Cuckle, Peter A. Benn, Multi-Marker Maternal Serum Screening for Chromosomal Abnormalities,